Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

now 10.33 what a total freak show

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,712
Posts 138,852
Boards Moderated 17
Alias Born 08/05/09
160x600 placeholder
Aravive EPS beats by $0.01, misses on revenue Seeking Alpha - 5/6/2021 7:26:21 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 7:15:18 AM
Aravive Reports First Quarter 2021 Financial Results and Announces Plans to Investigate AVB-500 in Clinical Trial as First-L... GlobeNewswire Inc. - 5/6/2021 7:00:00 AM
Aravive shares rise after dosing first patient in late-stage ovarian cancer study Seeking Alpha - 4/27/2021 10:54:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 7:11:36 AM
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant... GlobeNewswire Inc. - 4/27/2021 7:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/15/2021 7:45:28 AM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/24/2021 12:34:58 PM
Sec Staff Action/letter (sec Staff) Edgar (US Regulatory) - 3/24/2021 12:33:36 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/23/2021 7:06:44 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/22/2021 7:13:50 PM
Clovis Oncology, Marker Therapeutics leads healthcare gainers; Idera Pharmaceuticals, Praxis Precision Medicines among major ... Seeking Alpha - 3/19/2021 11:04:17 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/17/2021 4:07:28 PM
Aravive shares rise on Q4 results, pipeline updates Seeking Alpha - 3/16/2021 10:18:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/16/2021 7:16:07 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2021 7:11:57 AM
Aravive EPS beats by $0.27, beats on revenue Seeking Alpha - 3/16/2021 7:06:56 AM
Aravive Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates GlobeNewswire Inc. - 3/16/2021 7:00:00 AM
Aravive to Present Phase 1b Data Evaluating AVB-500 in Platinum Resistant Ovarian Cancer at 2021 Society of Gynecologic Oncol... GlobeNewswire Inc. - 3/12/2021 7:00:00 AM
Aravive shares rise 8% as BTIG initiates with a buy Seeking Alpha - 3/8/2021 10:28:42 AM
Aravive starts dosing in Phase 1b/2 AVB-500 cancer study Seeking Alpha - 3/8/2021 8:06:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/8/2021 7:05:50 AM
Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcino... GlobeNewswire Inc. - 3/8/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/2/2021 8:01:42 AM
Aravive to Participate in Upcoming Virtual Investor Conferences in March GlobeNewswire Inc. - 3/2/2021 7:00:00 AM
[SMART MONEY] Member Level  Wednesday, 11/20/19 10:29:34 AM
Re: Actualfactual post# 10
Post # of 51 
now 10.33 what a total freak show



Im out of this circus


sold @ 12.24



this one hurt alot of folks


imagine the capital loss from millions of shares bought up to almost $30 this morning

$100,000,000 dollars in volume so far


Im just thankful I didnt lose ANY

and thankful for FREE trades NO commissions




Always consult an Investment Professional, all communications
about stocks from me are my own opinions, and not for investing
decisions
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences